查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1701683

哺乳動物細胞庫市場：全球產業分析、規模、佔有率、成長、趨勢與預測（2025-2032）

Mammalian Cell Banking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 251 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計 2025 年全球哺乳動物細胞庫市場規模將達到 5.67 億美元，到 2032 年將達到 14.188 億美元，預測期內（2025-2032 年）的複合年成長率為 14.0%。

哺乳動物細胞庫市場涉及對生技藥品製造、基因治療和疫苗生產至關重要的哺乳動物衍生細胞株的開發、儲存和維護。細胞庫確保生物製藥生產的一致性、品質和安全性。隨著全球對單株抗體、細胞和基因療法以及個人化醫療的需求不斷增加，哺乳動物細胞庫已成為確保可靠和擴充性生產過程的關鍵要素。

由於多種促進因素​​，哺乳動物細胞庫市場正在經歷強勁成長。一個主要促進因素是對生技藥品和生物相似藥日益成長的需求，這需要穩定且特徵明確的哺乳動物細胞株來進行生產。人們對個人化醫療和細胞/基因治療的興趣日益濃厚，進一步加速了對安全、高品質細胞庫系統的需求。基於 CRISPR 的工程和高通量篩檢等細胞株開發技術的進步也促進了市場擴張。此外，對細胞庫使用良好生產規範 (GMP) 的監管支援正在提高產品品質和合規性，推動市場向前發展。

儘管哺乳動物細胞庫市場具有成長潛力，但也面臨一些挑戰。建立符合 GMP 標準的設施所需的高額初始投資和營運成本可能是一個重大障礙，尤其是對於中小型企業而言。此外，新細胞株的複雜而漫長的監管核准流程可能會減緩產品開發。長期儲存還存在與污染、基因漂變和變異相關的風險，這需要嚴格的品管和監控系統，從而增加了成本和複雜性。

哺乳動物細胞庫市場提供了大量的擴張和創新機會。涉及生技藥品和先進療法的臨床試驗的增加，特別是在腫瘤學和罕見疾病領域，正在推動多樣化和可靠細胞庫的需求。亞太和拉丁美洲的新興市場正在迅速擴大其生物製藥生產能力，提供了新的商業前景。此外，生物製藥公司和 CRO 擴大合作外包細胞庫服務，以提供擴充性和效率。對自動化和數位技術的投資，例如人工智慧驅動的品管和數位生物銀行平台，也為更高的標準化和卓越營運打開了大門。

本報告研究了全球哺乳動物細胞庫市場，並深入了解了各地區的趨勢、應用和最終用戶，以及參與市場的公司的概況。

目錄

第1章執行摘要

第2章 市場概述

第3章 主要市場趨勢

第4章 關鍵成功因素

  • 管道評估
  • 價值鏈分析
  • 各大廠商主要促銷策略
  • 監管狀況
  • PESTLE分析
  • 波特分析

第5章 市場背景

第6章 COVID-19 危機—影響評估

  • COVID-19 及其影響分析
  • 2022 年市場前景

7. 2019-2032年全球哺乳動物細胞庫市場展望

  • 2019-2024年歷史市場價值分析
  • 2025 年至 2032 年當前和未來市場價值預測

8. 2019-2032 年全球哺乳動物細胞庫市場展望（依細胞類型）

  • 簡介/主要發現
  • 2019 年至 2024 年按電池類型分類的歷史市場規模分析
  • 2025 年至 2032 年按電池類型分類的當前和未來市場規模分析與預測
  • 按細胞類型分析市場吸引力

9. 2019-2032 年全球哺乳動物細胞庫市場展望（依技術）

  • 簡介/主要發現
  • 2019 年至 2024 年按技術分類的歷史市場規模分析
  • 2025 年至 2032 年按技術分類的當前與未來市場規模分析與預測
  • 依技術進行市場吸引力分析

第 10 章 2019-2023 年全球哺乳動物細胞庫市場展望（按應用）

  • 簡介/主要發現
  • 2019 年至 2024 年按應用分類的歷史市場規模分析
  • 當前和未來市場規模分析與預測（按應用），2025 年至 2032 年
  • 按應用進行市場吸引力分析

第 11 章。 2019-2032 年全球哺乳動物細胞庫市場展望（按最終用戶分類）

  • 簡介/主要發現
  • 2019 年至 2024 年最終用戶市場規模歷史分析
  • 2025 年至 2032 年按最終用戶分類的當前和未來市場規模分析和預測
    • 學術研究所
    • 生物製藥公司
    • CRO
  • 最終用戶的市場吸引力分析

第 12 章。 2019-2032 年全球哺乳動物細胞庫市場展望（按地區）

  • 介紹
  • 2019 年至 2024 年各地區歷史市場規模分析
  • 2025 年至 2032 年各地區現今及未來市場規模分析與預測
    • 北美洲
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東和非洲
  • 區域市場吸引力分析

13. 北美哺乳動物細胞庫市場展望，2019 - 2032

14. 2019 - 2032 年拉丁美洲哺乳動物細胞庫市場展望

15. 2019-2032年歐洲哺乳動物細胞庫市場展望

16. 南亞哺乳動物細胞庫市場展望，2019-2032

17. 東亞哺乳動物細胞庫市場展望，2019-2032

18.大洋洲哺乳動物細胞庫市場

19. 中東和非洲哺乳動物細胞庫市場展望，2019 - 2032

第20章市場結構分析

第21章 競爭分析

  • 競爭儀錶板
  • 競爭基準
  • 衝突詳情
    • Eurofins DiscoverX Corporation
    • Merck KGaA
    • Sartorius Stedim BioOutsource Limited.
    • Charles River Laboratories
    • Altogen Labs
    • Abzena Ltd
    • Northway Biotechpharma
    • Lonza Group Ltd
    • VIRUSURE
    • Selexis SA
    • Sigma-Aldrich
    • Takara Bio Inc

第 22 章使用的假設和縮寫詞

第23章調查方法

簡介目錄
Product Code: PMRREP31663

Persistence Market Research has recently released a comprehensive report on the global Mammalian Cell Banking Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Mammalian Cell Banking Market Size (2025E): USD 567.0 Mn
  • Projected Market Value (2032F): USD 1,418.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 14.0%

Mammalian Cell Banking Market - Report Scope:

The mammalian cell banking market includes the development, storage, and maintenance of cell lines derived from mammalian cells, which are essential for biologics manufacturing, gene therapy, and vaccine production. Cell banks ensure consistency, quality, and safety in the production of biopharmaceuticals. As demand for monoclonal antibodies, cell and gene therapies, and personalized medicine increases globally, mammalian cell banking has become a critical component in ensuring reliable and scalable production processes.

Market Growth Drivers:

The mammalian cell banking market is experiencing strong growth driven by several influential factors. A major driver is the rising demand for biologics and biosimilars, which require stable and well-characterized mammalian cell lines for production. The increasing focus on personalized medicine and cell & gene therapies has further accelerated the need for secure and high-quality cell banking systems. Technological advancements in cell line development, such as CRISPR-based engineering and high-throughput screening, are also contributing to market expansion. In addition, regulatory support for the use of Good Manufacturing Practices (GMP) in cell banking enhances product quality and compliance, propelling the market forward.

Market Restraints:

Despite its growth potential, the mammalian cell banking market faces some challenges. High initial investment and operational costs associated with establishing GMP-compliant facilities can be a significant barrier, especially for small and mid-sized enterprises. Moreover, the complex and time-consuming regulatory approval processes for new cell lines can delay product development. There are also risks associated with contamination, genetic drift, or variability in long-term storage, which necessitate stringent quality control and monitoring systems, adding to the cost and complexity.

Market Opportunities:

The mammalian cell banking market presents numerous opportunities for expansion and innovation. The increasing number of clinical trials involving biologics and advanced therapies, particularly in oncology and rare diseases, is creating demand for diverse and reliable cell banks. Emerging markets in Asia-Pacific and Latin America are rapidly expanding their biopharmaceutical manufacturing capabilities, offering new business prospects. In addition, collaborations between biopharma companies and CROs to outsource cell banking services are on the rise, enabling scalability and efficiency. Investment in automation and digital technologies, such as AI-driven quality control and digital biobanking platforms, also opens doors for greater standardization and operational excellence.

Key Questions Answered in the Report:

  • What are the primary factors driving the global mammalian cell banking market's growth?
  • Which cell types and applications are dominating the mammalian cell banking landscape?
  • How are biopharmaceutical trends shaping future cell banking strategies?
  • Who are the key players in the mammalian cell banking market, and what strategies are they adopting?
  • What are the growth opportunities in emerging regions?

Competitive Intelligence and Business Strategy:

Leading companies in the mammalian cell banking market, such as Eurofins DiscoverX Corporation, Merck KGaA, Sartorius Stedim BioOutsource Limited, Charles River Laboratories, and Lonza Group Ltd, are focusing on expanding their GMP-compliant manufacturing facilities and enhancing service portfolios to meet global biopharma demand. Strategic partnerships with biotech firms and academic institutes, along with R&D investments in innovative cell line technologies, are key to maintaining a competitive edge. Companies are also emphasizing quality assurance, contamination prevention, and regulatory alignment to boost client confidence and streamline product development pipelines.

Companies Covered in This Report:

  • Eurofins DiscoverX Corporation
  • Merck KGaA
  • Sartorius Stedim BioOutsource Limited
  • Charles River Laboratories
  • Altogen Labs
  • Abzena Ltd
  • Northway Biotechpharma
  • Lonza Group Ltd
  • VIRUSURE
  • Selexis SA
  • Takara Bio Inc

Key Segments Covered in Manufacturing of Industry Research:

Cell Type:

  • CHO
  • BHK
  • NS0
  • YB2/0 & P2/0
  • HEK293 & Derivatives
  • HELA

Technology:

  • TEP
  • IEP
  • SEP

Application:

  • MCB (Master Cell Bank)
  • WCB (Working Cell Bank)
  • EoP (End of Production)
  • R&D CB (Research & Development Cell Bank)

End User:

  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • CROs (Contract Research Organizations)

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Development/Innovation Trends

4. Key Success Factors

  • 4.1. Pipeline Assessment
  • 4.2. Value chain Analysis
  • 4.3. Key Promotional Strategies, By Key Manufacturers
  • 4.4. Regulatory Landscape
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Cell Banking Outsourcing Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Key Player's Historic Growth
    • 5.2.2. Market Consolidation Activities
    • 5.2.3. Increasing Geriatric Population
    • 5.2.4. Rising Cases of Cancer
    • 5.2.5. Growing Preference of Mammalian Cell Banking
    • 5.2.6. Increased R&D investments by Government
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Cell
    • 6.1.2. By Technology
    • 6.1.3. By Application
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2022 Market Scenario

7. Global Mammalian Cell Banking Market Outlook, 2019-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Cell

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Cell, 2019-2024
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell, 2025-2032
  • 8.4. Market Attractiveness Analysis By Cell

9. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Technology

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) By Technology, 2019-2024
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2025-2032
  • 9.4. Market Attractiveness Analysis By Technology

10. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2024
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2025-2032
  • 10.4. Market Attractiveness Analysis By Application

11. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) By End User, 2019-2024
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2025-2032
    • 11.3.1. Academic & Research Institute
    • 11.3.2. Biopharmaceutical Companies
    • 11.3.3. CROs
  • 11.4. Market Attractiveness Analysis By End User

12. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2025-2032
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Mammalian Cell Banking Market Outlook, 2019-2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
  • 13.4. Market Attractiveness Analysis
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Mammalian Cell Banking Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 13.8.2. Canada Mammalian Cell Banking Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy

14. Latin America Mammalian Cell Banking Market Outlook, 2019-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
  • 14.4. Market Attractiveness Analysis
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Mammalian Cell Banking Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 14.8.2. Brazil Mammalian Cell Banking Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 14.8.3. Argentina Mammalian Cell Banking Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy

15. Europe Mammalian Cell Banking Market Outlook, 2019-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 15.3.1. By Country
      • 15.3.1.1. Italy
      • 15.3.1.2. Germany
      • 15.3.1.3. U.K
      • 15.3.1.4. France
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Nordic Countries
      • 15.3.1.8. Russia
      • 15.3.1.9. Rest of Europe
  • 15.4. Market Attractiveness Analysis
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Italy Mammalian Cell Banking Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.2. Germany Mammalian Cell Banking Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.3. U.K. Mammalian Cell Banking Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.4. France Mammalian Cell Banking Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.5. Spain Mammalian Cell Banking Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.6. BENELUX Mammalian Cell Banking Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.7. Nordic Countries Mammalian Cell Banking Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
    • 15.8.8. Russia Mammalian Cell Banking Market Analysis
      • 15.8.8.1. Introduction
      • 15.8.8.2. Market Analysis and Forecast by Market Taxonomy

16. South Asia Mammalian Cell Banking Market Outlook, 2019-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Cell
  • 16.4. Market Attractiveness Analysis
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Mammalian Cell Banking Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 16.8.2. Indonesia Mammalian Cell Banking Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 16.8.3. Malaysia Mammalian Cell Banking Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
    • 16.8.4. Thailand Mammalian Cell Banking Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy

17. East Asia Mammalian Cell Banking Market Outlook, 2019-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
  • 17.4. Market Attractiveness Analysis
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. China Mammalian Cell Banking Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 17.8.2. Japan Mammalian Cell Banking Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    • 17.8.3. South Korea Mammalian Cell Banking Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy

18. Oceania Mammalian Cell Banking Market 2019-2024 and Forecast 2025-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
  • 18.4. Market Attractiveness Analysis
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Mammalian Cell Banking Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 18.8.2. New Zealand Mammalian Cell Banking Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy

19. Middle East and Africa (MEA) Mammalian Cell Banking Market Outlook, 2019-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkey
      • 19.3.1.3. South Africa
      • 19.3.1.4. North Africa
      • 19.3.1.5. Rest of Middle East and Africa
  • 19.4. Market Attractiveness Analysis
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Mammalian Cell Banking Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
    • 19.8.2. Turkey Mammalian Cell Banking Market Analysis
    • 19.8.3. South Africa Mammalian Cell Banking Market Analysis
    • 19.8.4. North Africa Mammalian Cell Banking Market Analysis

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players (%)
  • 20.3. Market Presence Analysis
    • 20.3.1. By Regional Footprint of Players
    • 20.3.2. Cell Footprint of Players
    • 20.3.3. Channel Footprint of Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Eurofins DiscoverX Corporation
      • 21.3.1.1. Overview
      • 21.3.1.2. Product & Services Portfolio
      • 21.3.1.3. Key Financials
      • 21.3.1.4. SWOT Analysis
      • 21.3.1.5. Key Developments
      • 21.3.1.6. Sales Footprint
      • 21.3.1.7. Strategy Overview
        • 21.3.1.7.1. Marketing Strategy
        • 21.3.1.7.2. Product Strategy
        • 21.3.1.7.3. Channel Strategy
    • 21.3.2. Merck KGaA
    • 21.3.3. Sartorius Stedim BioOutsource Limited.
    • 21.3.4. Charles River Laboratories
    • 21.3.5. Altogen Labs
    • 21.3.6. Abzena Ltd
    • 21.3.7. Northway Biotechpharma
    • 21.3.8. Lonza Group Ltd
    • 21.3.9. VIRUSURE
    • 21.3.10. Selexis SA
    • 21.3.11. Sigma-Aldrich
    • 21.3.12. Takara Bio Inc

22. Assumptions and Acronyms Used

23. Research Methodology